Affomix, City of Hope Collaborate to Create Proteomic Profiles of Cancer

Affomix will supply City of Hope with monoclonal antibodies that will be used to create proteomic profiles that are characteristic of a number of cancers such as renal and prostate cancers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.